US EditionPublished • loading... • Updated
CDC to Conduct Hepatitis B Vaccine Trial in Guinea-Bissau, Raising Ethical Concerns
Summary by thehoya.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CDC to Conduct Hepatitis B Vaccine Trial in Guinea-Bissau, Raising Ethical Concerns
The U.S. Centers for Disease Control and Prevention (CDC) approved a $1.6 million grant to fund a study on the efficacy of the hepatitis B vaccine Dec. 15, 2025. After U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. proposed outsourcing the study to Guinea-Bissau, the Bissau-Guinean government suspended the study following significant backlash from scientists and global health… Source
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
